Evidence map›Paper›PMID 42554929›Full record

ReviewApplied biochemistry and biotechnology2026

A Comprehensive Review of Recent Advances in Sustainable Synthesis of Bio-Based Furanic Compounds Via Chemical, Biological, Chemobiological and Other Combination Approach in Benign Systems.

Shaojie Jiang, Yu-Cai He

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shaojie JiangSchool of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, China.
Yu-Cai HeSchool of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, China. heyucai2001@126.com.ORCID http://orcid.org/0000-0002-0973-1788

Funding

Frontiers Technology Research and Development Plan of Jiangsu Province BF2025080
6 · The paper itself

Abstract

With the global population growth and the accelerating industrialization process, the demand for chemical intermediates and basic chemicals has been continuously rising. Against this backdrop, the conversion of renewable lignocellulosic biomass into high-value platform molecules has emerged as a strategic direction for achieving carbon neutrality and biorefining. This review systematically explores the synthetic routes of bio-based furan compounds (especially furfural, 5-hydroxymethylfurfural, and furfurylamine) and their recent industrial and technological advancements. By in-depth analysis of the microscopic deconstruction mechanisms of cellulose, hemicellulose, and lignin, this report elaborates on the chemical evolution process from polysaccharide degradation to furan ring formation, and highlights the outstanding performance of combinatorial catalysis, especially chemoenzymatic catalysis methods, in improving reaction selectivity. Meanwhile, the report also integrates the crucial role of emerging green solvent systems, such as deep eutectic solvents (DESs) and ionic liquids (ILs) in suppressing corrosion and side reactions. Finally, an in-depth study is conducted on the synthesis of furan products driven by AI and computer simulation. This review aims to provide researchers and industrial decision-makers with in-depth insights into the bio-based furan value chain, identify technological bottlenecks, and point out the future path towards a low-carbon chemical industry.

Indexed as

Benign systemChemoenzymatic catalysisFuranic platform moleculesLignocellulosic biomass

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.